Fiber-type vulnerability and proteostasis reprogramming in skeletal muscle during pancreatic cancer cachexia
JCI Insight · 23.03.2026 · 11 (6)
DOI: 10.1172/jci.insight.200396 ↗Kurz gefasst
Fachartikel in der Zeitschrift JCI Insight, online erschienen am 27.01.2026. Verfasst von Bowen Xu und 4 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Muscle Biology and Cachexia, University of Houston College of Pharmacy, Houston, Texas, USA. Hauptthemen laut MEDLINE: Cachexia, Pancreatic Neoplasms, Proteostasis, Muscle, Skeletal. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAMS NIH HHS, NCI NIH HHS, National Institute of Arthritis and Musculoskeletal and Skin Diseases.
Abstract (Originalsprache)
Cachexia is a debilitating syndrome characterized by progressive skeletal muscle wasting, commonly affecting patients with cancer, particularly those with pancreatic cancer. Despite its clinical significance, the molecular mechanisms underlying cancer cachexia remain poorly understood. In this study, we utilized single-nucleus RNA-seq (snRNA-seq) and bulk RNA-seq, complemented by biochemical and histological analyses, to investigate molecular alterations in the skeletal muscle of the KPC mouse model of pancreatic cancer cachexia. Our findings demonstrated that KPC tumor growth induced myofiber-specific changes in the expression of genes involved in proteolytic pathways, mitochondrial biogenesis, and angiogenesis. Notably, tumor progression enhanced the activity of specific transcription factors that regulate the mTORC1 signaling pathway, along with genes involved in translational initiation and ribosome biogenesis. Skeletal muscle–specific, inducible inhibition of mTORC1 activity further exacerbated muscle loss in tumor-bearing mice, highlighting its protective role in maintaining muscle mass. Additionally, we uncovered new intercellular signaling networks within the skeletal muscle microenvironment during pancreatic cancer–induced cachexia. Our study reveals previously unrecognized molecular mechanisms that regulate skeletal muscle homeostasis, and it identifies potential therapeutic targets for the treatment of pancreatic cancer–associated cachexia.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Muscle Biology and Cachexia, University of Houston College of Pharmacy, Houston, Texas, USA.
- Department of Biomedical engineering, Cullen College of Engineering, University of Houston, Houston, Texas, USA.
- Department of Pharmacological and Pharmaceutical Sciences, University of Houston College of Pharmacy, Houston, Texas, USA.
Förderung
- NIAMS NIH HHS
- NCI NIH HHS
- National Institute of Arthritis and Musculoskeletal and Skin Diseases
- National Cancer Institute
Zitieren
APA
Xu, B., Joshi, A. S., Tomaz da Silva, M., Liu, S., & Kumar, A. (2026). Fiber-type vulnerability and proteostasis reprogramming in skeletal muscle during pancreatic cancer cachexia. JCI Insight, 11(6). https://doi.org/10.1172/jci.insight.200396
Vancouver
Xu B, Joshi AS, Tomaz da Silva M, Liu S, Kumar A. Fiber-type vulnerability and proteostasis reprogramming in skeletal muscle during pancreatic cancer cachexia. JCI Insight. 2026;11(6). doi:10.1172/jci.insight.200396
BibTeX
@article{Xu2026,
author = {Xu, Bowen and Joshi, Aniket S and Tomaz da Silva, Meiricris and Liu, Silin and Kumar, Ashok},
title = {Fiber-type vulnerability and proteostasis reprogramming in skeletal muscle during pancreatic cancer cachexia},
journal = {JCI Insight},
year = {2026},
volume = {11},
number = {6},
doi = {10.1172/jci.insight.200396}
}
EUVIMED